Source: Pharmabiz

Sanofi: Alloy Therapeutics announces target specific collaboration & license agreement for use of AntiClastic Antisense platform with Sanofi for CNS target

Alloy Therapeutics Inc. (Alloy), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug discovery technologies,

Read full article »
Annual Revenue
$50-100B
Employees
50-100K
Paul Hudson's photo - CEO of Sanofi

CEO

Paul Hudson

CEO Approval Rating

63/100

Read more